Challenging Patients: Elderly Patient With Multiple Co morbidities Essentials of Family Medicine 1
|
|
- Cecily Bishop
- 6 years ago
- Views:
Transcription
1 Prescribing in the Elderly Resident s Guide Case 1 Mr. P R is a 90 y/o male with HTN, Type 2 DM, hyperlipidemia, peripheral neuropathy, visual impairment, hearing impairment and disequilibrium. Although he no longer drives secondary to visual impairment, he is otherwise functionally independent, and enjoys reading, taking walks with his wife and his family. He presents now with 3 falls in the past 4 weeks. He has no new symptoms all of the falls involved losing his balance. He has not had syncope, and he fortunately has not suffered serious injury. He otherwise feels well and has had no changes in his daily routine. He has had no symptoms of hypoglycemia Medication list Hctz 25 mg a day Amlodipine 5 mg a day Lisinopril 40 mg a day Metoprolol 25 mg bid Metformin XR 1 gm a day Simvastatin 40 mg a day ASA 81 mg a day Vital signs AF, R 16, Supine BP 120/70, P 68. Standing BP 100/60, P 72 (orthostasis new) Has several bruises on his shins, but otherwise his exam shows a non focal neuro exam, with no obvious change in his long standing peripheral neuropathy. On getup and go test he has normal muscle strength, and some gait unsteadiness. Labs are remarkable for a Na+ of 125 (baseline 132), K+ 4.6, BUN 18, Cr 0.9, BS 147. Case Discussion Instructions 1. On an index card: Write the changes you recommend making in his medication list. 2. Reader reads these changes 3. Discuss medication list and changes using the CHAMP approach and in light of his recent falls.
2 Case 1 Instructor s Guide Discussion Mr. P R presents with new onset of frequent falls. He has no evidence of new neurologic event. He has multiple reasons why he might fall vision impairment, peripheral neuropathy and disequilibrium. New findings include orthostasis and hyponatremia. All of his BP medications can contribute to orthostasis, and several can contribute to the development of hyponatremia. As both the hyponatremia and orthostasis increase his fall risk, one or more of the anti hypertensives should be discontinued. Cost and Compliance His medications are all available in generic forms, most are on the $4 drug list at many pharmacies. His wife has always monitored his medications and he rarely forgets to take them Hazardous Interactions There are several interactions here Amlodipine Hctz Amlodipine Lisinopril Hctz Lisinopril Amlodipdine Metoprolol Lisinopril Metoprolol Hctz Metoprolol These interactions are all related to synergestic blood pressure lowering affects, and all of these medications can be prescribed safely together with appropriate monitoring There is a theoretical risk of metoprolol masking signs of hypoglycemia in a patient on metformin. Aging Pharmacology HCTZ Older adults are more susceptible to hctz induced hyponatremia. HCTZ increases Na+ excretion at the level of the distal tubule Lisinopril ACE I can cause SIADH, perhaps by increased levels of angiotensin 1 crossing the blood brain barrier, leading to conversion to angiotension 2, which then acts on the pituitary to increase ADH release
3 Case 1 Metoprolol blockers can further blunt impaired baroreceptor reflexes in older adults. Older adults adrenergic receptors are also less responsive to blockade, so that blockers may be less effective anti hypertensive agents in the elderly. Metformin Theoretical concern for lactic acidosis exists in older patients due to decline in renal function. Medications to Avoid None of these medications are contraindicated in the elderly Medication Review He is on multiple anti hypertensives, and at least one should be discontinued due to his orthostasis. Polypharmacy more medication than is clinically indicated The patient is now normotensive and orthostatic, suggesting that he no longer requires all of his blood pressure medication.
4 Prescribing in the Elderly Resident s Guide Case 2 Mrs. CB is a 71 y/o woman with a h/o multiple sclerosis, htn, depression, breast ca, s/p mastectomy, ER+, and DVT. She is wheel chair bound secondary to her multiple sclerosis and lives in a nursing home. She has recent symptoms of urgency and dysuria. She has had no fever, and o/w feels at baseline. A nurse calls you (on call) on a Saturday with a report that the patient s urine culture has grown E.coli sensitive only to trimethoprim/sulfamethoxazole, ciprofloxacin and amikacin. She is afebrile and her vital signs are normal. Medication list Interferon sub q weekly Femara 5 mg q day Coumadin 4 mg a day Lisinopril 20 mg a day Hctz 25 mg a day Celexa 10 mg a day Case Discussion Instructions 1. On an index card: Write any additional information you would like to have, and what you recommend prescribing. 2. Reader reads the answers on the cards 3. Discuss potential interactions and what can be done to minimize the risk of these interactions. Include the antibiotics discussed.
5 Case 2 Instructor s Guide Discussion The on call resident, the nurse and the patient are now stuck between the proverbial rock and a hard place. The patient has a symptomatic UTI, and the only oral medications both interact with Coumadin. The aminoglycoside, which can be given daily for uncomplicated UTI, must be given by injection. Important information that must be known before a well informed decision can be made include the patient s weight and creatinine (or the most recent creatinine clearance), and the patient s INR. The patient s INR is 2.6, her Cr is 1.8, and her weight is 74 kg. What is her estimated creatinine clearance? Important interactions to consider include Sulfamethoxazole and Coumadin. Sulfamethoxazole interferes with the hepatic metabolism of the s isomer of Coumadin. This is the most active form of Coumadin. On average, sulfa will produce the greatest rise in INR of any antibiotic, and should be avoided. Ciprofloxacin also interferes with the metabolism of Coumadin, through a variety of medications, including affect on gut flora and inhibition of metabolism. The affect on INR is more variable, and while ciprofloxacin and other quinolones should be avoided, if possible, cipro can be given with either reduction of the coumadin dose and/or close monitoring of the INR. The safest choice for this patient is amikacin, which can be given once daily in this patient due to her creatinine clearance. This patient was actually seen in the emergency room and placed on bactrim. Several days later she developed a severe headache. She was found to have a subdural hemorrhage, and an INR of 7.5. She underwent craniotomy with removal of a portion of her parietal bone for decompression. Always check for potential interactions when prescribing a medication for a patient on Coumadin.
6 Prescribing in the Elderly Resident s Guide Case 3 Mr. W is an 85 y/o man with a h/o CAD, CHF, HTN and a fib admitted for chest pain and CHF exacerbation. He is felt to have ischemia secondary to strain related to his CHF. He is placed on his home medications and his lasix dose is increased. You are called on night float on his second hospital day because he has become hypotensive. He denies chest pain, and his shortness of breath is better than it was on admission. VS: P 56, R18, BP 85/40, T The patients lungs are clear, and he has no JVD or HJR. He does not appear acutely ill. His EGK is without change from admission, and shows no evidence of acute ischemia. Medication list Metoprolol 50 mg BID Lisinopril 20 mg BID Verapamil SR 120 mg BID Warfarin 5 mg q day KCL 10 meq q day ASA 81 mg a day Isosorbide dinitirate, 20 mg tid Lasix 60 mg BID (home dose 20 mg bid). Afternoon labs INR 4.5, BUN 24, CR 1.2 (baseline 1 to 1.3), hgb 13.8 Case Discussion Instructions 1. On an index card, write your differential for the patient s hypotension and elevated INR. 2. Reader reads answers 3. As a group, apply the CHAMP approach to this patient s medication list and discuss.
7 Case 3 Instructor s guide Discussion The patient presents with hypotension during treatment for a congestive heart failure exacerbation. The absence of chest pain and an EKG without acute changes lowers the likelihood that ischemia is the cause. The absence of fever and generally well appearance makes sepsis less likely. The elevated INR should raise suspicion for hemorrhage, and this needs to be considered, despite the recent normal Hgb. The absence of dyspnea and well appearance, and his anticoagulation status makes a PE less likely. While overdiuresis needs to be a consideration in this setting, the relatively normal BUN/Cr ratio coupled with baseline creatinine lowers the likelihood that this is the culprit. This patient s hypotension was due to compliance. At home he was not able to manage this fairly complicated drug regimen, and thus did not take his medications as prescribed. In the hospital he was prescribed his medication list, without reviewing it carefully with him. Since he was now being given all of his medications, he suffered an adverse drug event. The goal now is to streamline his medication regimen, using as simple and effective a regimen as possible. Cost and Compliance This regimen is comprised of generically available drugs, and could be purchased for less than $50/month. Compliance is obviously an issue. Hazardous Interactions Verapamil metoprolol bradycardia, heart block blockers and nitrates hypotension Asa and warfarin increased risk of bleeding; enalapril and k+ hyperkalemia Drug disease interaction verapamil and CHF increased mortality in CHF Aging pharmacology Pharmacodynamics Verapamil increased receptor sensitivity leads to more constipation and a greater HR response Coumadin increased receptor sensitivity to Coumadin Pharmacokinetics Verapimil is a high first pass clearance drug, and decreased clearance in aging
8 Case 3 Medications to avoid Avoid aspirin with anticoagulants Avoid verapamil in patients with CHF and constipation Polypharmacy The patient is on several medications that may not be needed or whose risk exceeds the benefits. Consider tapering/discontinuing verapamil, aspirin and isosorbide.
9 Prescribing in the Elderly Resident s guide Case 4 Mr. RW is a 90 y/o man with moderate Alzheimer s dementia, dysphagia, CKD (baseline Cr = 3.0), agitation and gout, admitted with nausea and vomiting, refusing food and drink. He is afebrile, his vital signs are normal, and he has a benign abdominal exam. Lab work is within normal limits, apart from an elevated BUN/CR. He lives with his wife, who is his primary caregiver. She is 86 y/o and in poor health. At baseline, he is able to ambulate and feed himself, but needs help with bathing, dressing and toileting. Medication list Exelon, 6 mg BID Triamterene/HCTZ 37.5/25 daily Seroquel 25 mg daily Levothyroxine 50 mcg a day Trazodone, 50 mg a day Alprazolam, 0.25 mg qhs Colchicine, 0.6 mg a day Tolterodine, 0.4 mg a day Case Discussion Instructions 1. On a note card, write down medications you would stop 2. Read these aloud 3. As a group, discuss this patient s medication list using the CHAMP approach. 4. Could any of his medications cause his nausea and vomiting?
10 Case 4 Instructor s guide Discussion This patient s nausea and vomiting could be secondary to Exelon (common side effect), or colchicine (particularly if he is taking this incorrectly). Cost and Compliance Exelon and seroquel are both expensive medications. How is he taking the medication? Who is monitoring medication adherence? Hazardous Interactions Seroquel Trazodone Xanax: increased risk of sedation, psychomotor impairment (synergestic effects) Exelon tolterodine: Exelon is pro cholinergic; tolterodine is anti cholinergic. These two drugs have antagonistic effects, and Exelon will likely decrease effectiveness of tolterodine. Disease Drug interactions: Thiazide diuretics gout: thiazides increase uric acid and risk of gout attack Benzodiazapine dementia: increase risk of falls Seroquel and dementia increased risk of death in patients with dementia taking antipsychotices. Aging pharmacology Pharmacodynamics Benzodiazepine increased receptor sensitivity leads to more CNS side effects Pharmacokinetics Xanax is fat soluble, older patients have lower lean body mass volume of distribution increased, leading to longer t ½ Xanax is metabolized by hepatic oxidative pathway, which is decreased in elderly, and has active metabolites, leading to prolonged t ½.
11 Case 4 Medications to avoid Avoid benzodiazapines in patients with dementia (falls, confusion) Avoid thiazides in patients with gout Avoid colchicine in patients with significant CKD Polypharmacy Patient is on several medications that interact with underlying diseases, or with each other, or may synergistically cause CNS side effects, or may not be effective. His triamterne/hctz should be discontinued, and another BP medication substituted. This may, in itself, decrease risk of gout enough to stop his colchicine. His alprazolam should be stopped, as well. An effort should be made to stop his trazodone its effectiveness in agitation is not proven. His tolteridone should also be discontinued, with monitoring for recurrence of GU symptoms.
12 Prescribing in the Elderly Resident s guide Case 5 Mr. EW is a 77 y/o male with h/o HTN, CAD s/p CABG and CKD, stage 3, BPH and hyperlipidemia. His wife brings him in because of concern for several weeks of trouble swallowing, decreased oral intake, trouble urinating and fatigue. About 3 weeks ago had developed nasal congestion and a cough. He was seen at an urgen care center, and placed on moxifloxacin (completed 5 days ago), diphenhydramine and pseudoephedrine. On exam he is afebrile, with BP 115/72, P 74, R 16, T He has lost 2 kg since last visit 4 weeks ago. His exam is o/w unremarkable, and he has a non focal neuro exam. Medication List Lisinopril 20 mg a day Lopressor 50 mg BID ASA 81 mg a day Simvastatin 40 mg a day Diphenhydramine, 25 mg qid Pseudoephedrine, 30 mg tid Guiafenisin prn. Case Discussion Instructions 1. Write, on a notecard, your differential diagnosis 2. Reader reads cards 3. Analyze medication list using CHAMP and discuss as a group.
13 Case 5 Instructor s guide Discussion The patient has the subacute onset of trouble swallowing and decreased oral intake after being treated for what was likely a viral URI. In this setting, the most likely etiology of these symptoms is an ADR/ADE, likely secondary to diphenhydramine and pseudophedrine. Other possibilities include an esophageal web or stricture, GERD, oropharyngeal muscle dysfunction, or a degenerative neurologic disease. Cost and Compliance This is a fairly inexpensive medical regimen. Need to ascertain how he is taking medications. Hazardous Interaction Drug Drug Interaction Lisinopril metoprolol: Increased blood pressure lowering through synergestic effects. Pseudoephedrine lisinopril/metoprolol antagonistic effects. Pseudoephedrine may lessen anti hypertensive effectiveness. Drug Disease Interaction Pseudoephedrine BPH: pseudoephedrine, as an agonist, may lead to increased difficulty urinating or urinary retention in men with BPH. Aging pharmacology Pharmacodynamics Diphenhydramine: Increased receptor sensitivity, enhanced anticholinergic profile. Medications to avoid Diphenhydramine Polypharmacy On more than 5 meds. Several may not be needed any longer. No clear indication now for diphenhydramine and pseudoephedine.
Difficult to Treat Hypertension
Difficult to Treat Hypertension According to Goldilocks JNC 8 Blood Pressure Goals (2014) BP Goal 60 years old and greater*- systolic < 150 and diastolic < 90. (Grade A)** BP Goal 18-59 years old* diastolic
More informationSTART, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy
START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment
More informationHypertension Pharmacotherapy: A Practical Approach
Hypertension Pharmacotherapy: A Practical Approach Ronald Victor, MD Burns & Allen Chair in Cardiology Director, The Hypertension Center Associate Director, The Heart Institute Hypertension Center 1. 2.
More informationPolypharmacy: So Many Drugs, So Little Time. Shannon O. Smith, MD General Internal Medicine Conference
Polypharmacy: So Many Drugs, So Little Time Shannon O. Smith, MD General Internal Medicine Conference Objectives 1. Recognize polypharmacy and what it means to your patients 2. Fix it. Patient Susie Q
More informationDefinition : Stages : ( RIFLE vs. AKIN ) Causes and classification : Pre-renal Renal Post- renal Clinical manifestations and Complication Management
AKI Definition : Stages : ( RIFLE vs. AKIN ) Causes and classification : Pre-renal Renal Post- renal Clinical manifestations and Complication Management and indications for RRT Etiology prerenal causes
More informationMaximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016
Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Adverse Drug Events (ADE s) RISK FACTORS FOR Adverse Drug Events (ADEs) 6 or more concurrent chronic conditions 12 or more doses of drugs/day
More informationBLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative
BLCS 1-Clinical Overview Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative Fraser Health Guide To Person-Centered Medication Decisions Factors to Consider When Systematically
More informationROAD TO UNDERSTANDING POLYPHARMACY. Lt Col PHIL L. SAMPLES BS Phr, Pharm. D., BCNSP
ROAD TO UNDERSTANDING POLYPHARMACY Lt Col PHIL L. SAMPLES BS Phr, Pharm. D., BCNSP Definition occurs when: 1. a medical regimen includes at least one unnecessary medication 2. Medications have not been
More informationAlzheimer s Disease, Dementia, Related Disorders
Alzheimer s Disease, Dementia, Related Disorders Stage 7 on the FAST Scale signifies the threshold of activity limitation that would support a six-month prognosis. The FAST Scale does not address the impact
More informationHow to Teach About Drugs and Aging
How to Teach About Drugs and Aging Brandon Koretz MD Assistant Clinical Professor Division of Geriatrics Challenges Prescription pad:internist::scalpel: Surgeon Artificial split between theory and practice
More informationGeriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center
Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)
More informationPolypharmacy and Elders. Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging
Polypharmacy and Elders Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging Prescription Medication Use In Elders 1 13% of the US population is age 65+ Age 65 years 13% Age 65+ account for 34% of
More informationWednesday September 20 th CMT Regional Study Day. Dr Colin Mason, Consultant DME, Addenbrooke s Hospital
Wednesday September 20 th CMT Regional Study Day Dr Colin Mason, Consultant DME, Addenbrooke s Hospital Develop a structured approach to a patient presenting with a fall Risk stratify who can go home and
More informationCase 1. Case 2. What do you think about reducing or discontinuing some of the above now that his LVEF has normalized?
Case 1 A primary care colleague inquires what to do with a patient (HFrEF in NSR) who has a digoxin level of 2.8ng/ml. Level was obtained at 10am, patient takes all medications at one time upon arising
More informationCase #1. 73 y/o man with h/o HTN and CHF admitted with dizziness and SOB Treated for CHF exacerbation with Lasix Now HR 136
Tachycardias Case #1 73 y/o man with h/o HTN and CHF admitted with dizziness and SOB Treated for CHF exacerbation with Lasix Now HR 136 Initial Assessment Check Telemetry screen if pt on tele Telemetry
More informationCOMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
More informationObjectives. The Good, The Bad and The Iatrogenic. The FDA Package Insert renal dosing is dependent on. Nephrology Axiom 4/10/15
The Good, The Bad and The Iatrogenic Kim Zuber, PAC Metropolitan Nephrology Alexandria, VA Disclosures: none Objectives 1) By CKD stage, review common medications taken by CKD patients 2) By CKD stage,
More informationGeri-PARDY! (2015 Beers Criteria) Pharmacology Edition
Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria
More informationTopic: Chronic Heart Failure Cases for Monday s March 21th lecture.
1 Phar6122: CV section Date: 3/10/05 Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. Directions: This handout includes three chronic heart failure cases of increasing difficulty. In
More informationDeath by Bedrest: The Perils of The Hospital
Death by Bedrest: The Perils of The Hospital Mindy Fain, MD Professor of Clinical Medicine Director, Arizona Reynolds Program of Applied Geriatrics Section Head, Geriatrics & Gerontology University of
More informationSCRIPT 1 - PHYSICIAN COMMUNICATION Localizing Signs and Symptoms with Warning Signs
SCRIPT 1 - PHYSICIAN COMMUNICATION Localizing Signs and Symptoms with Warning Signs Wisconsin Healthcare Associated Infections in LTC Coalition PHONE CONTACT NECESSARY Resident: Jimmy Issick Date: 11/7/15
More informationThe Failing Heart in Primary Care
The Failing Heart in Primary Care Hamid Ikram How fares the Heart Failure Epidemic? 4357 patients, 57% women, mean age 74 years HFSA 2010 Practice Guideline (3.1) Heart Failure Prevention A careful and
More informationInstruct patient and caregivers: Need for constant monitoring Potential complications of drug therapy
Assessment Prior to administration: Assess patient for chest pain, dysrhythmias, and vital signs (initially and throughout therapy) Obtain complete medical history, including allergies, especially heart
More informationCase Studies in T2DM A Comprehensive Management Approach
Case Studies in T2DM A Comprehensive Management Approach John E. Anderson, MD The Frist Clinic Nashville, TN 43 yo Latina woman with 5 yrs T2DM. Originally diagnosed with PCOS and IGT by GYN at 32 yo.
More informationMEDICATION APPROPRIATENESS FOR THE AGING POPULATION. Building Partnerships for Successful Aging
MEDICATION APPROPRIATENESS FOR THE AGING POPULATION Building Partnerships for Successful Aging Learning objectives Appreciate complexities involved in making appropriate clinical decisions in older adults
More informationFairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45
Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45 1. Your diabetic patient is to be started on an insulin drip at 8 units/hour. The insulin is supplied: 100 units in
More informationGeriatric Pharmacology
Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological
More informationHeart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid
Failure? blood supply insufficient for body needs CHF = congestive heart failure increased blood volume, interstitial fluid Underlying causes/risk factors Ischemic heart disease (CAD) 70% hypertension
More informationPharmacology. Definitions. Pharmacology Definitions 8/20/2013. Drug:
Pharmacology Medications and their potential implications in physical therapy Definitions Drug: Any substance that alters physiologic function in the organism, regardless of whether the effect is beneficial
More informationObjectives 2/11/2016 HOSPICE 101
HOSPICE 101 Overview Hospice History and Statistics What is Hospice? Who qualifies for services? Levels of Service The Admission Process Why Not to Wait Objectives Understand how to determine hospice eligibility
More informationChapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories
Chapter 23 Drugs for Hypertension Slide 37 Slide 41 Media Directory Nifedipine Animation Doxazosin Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cardiovascular Disease (CVD) Includes
More informationTopic: Chronic Heart Failure Cases for Monday s March 21th lecture.
1 Phar6122: CV section Date: 3/21/05 Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. Directions: This handout includes three chronic heart failure cases of increasing difficulty. In
More informationDiabetes and the Elderly: Medication Considerations When Determining Benefits and Risks
Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Gretchen M. Ray, PharmD, PhC, BCACP, CDE Associate Professor UNM College of Pharmacy September 7 th, 2018 DISCLOSURES
More informationJennifer Loh, MD, FACE Chief of Endocrinology KP Hawaii AAMD of Medical Education, KP Hawaii
Individualized Diabetes Treatment for the Elderly Jennifer Loh, MD, FACE Chief of Endocrinology KP Hawaii AAMD of Medical Education, KP Hawaii Extremely Relevant Baby Boomers are aging! ¼ of people age
More informationSTOPP and START criteria October 2011
# START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which
More informationDoes Adding Examples to the American Society of Anesthesiologists Physical Status Classification Improve Consistency in Assignment to Patients?
Does Adding Examples to the American Society of Anesthesiologists Physical Status Classification Improve Consistency in Assignment to Patients? Submitted Abstract to the 2015 ASA Annual Meeting 10 Hypothetical
More informationConsultant Pharmacist Report
A WOODWARD, BOBBIE Room #: A001A INSOMNIA PETIT, ANDIE Room #: A002B Lab Reminder Since the coumadin dose was increased on 6-29 and the antibiotic (Duricef) has been given, please check an INR. (Last done
More informationAdvanced Pharmacology Diabetes Homework
Advanced Pharmacology Diabetes Homework Points: 25 Comments: Name: Tracy Hill WU ID #: 20015608 E-mail: tracy.hill@washburn.edu _TH I hereby certify that the work submitted is my own, and that I have not
More informationHypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015
Hypertension Update Beverly J. Mathis, D.O. OOA May 2015 Objectives Learn new recommendations for BP treatment goals Approach to hypertension in the office Use of hypertensive drugs, and how to tailor
More informationCost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib
Atrial Fibrillation: Guideline Directed Treatment Melissa Wendell, FNP-C, MSN Heart Failure - Lead Nurse Practitioner, Aspirus Wausau Hospital and Aspirus Cardiology Cost and Prevalence of A fib 33.5 million
More informationInterprofessional Outpatient Clinic Polypharmacy Management. Objectives
Interprofessional Outpatient Clinic Polypharmacy Management Brett Hoffecker, MD University of Kansas School of Medicine Wichita Family Medicine Residency Program at Via Christi April 10th, 2015 Objectives
More informationClinical Pearls in Renal Medicine
Clinical Pearls in Renal Medicine Joel A. Gordon MD Professor of Medicine Nephrology Division Staff Physician Kidney Disease and Blood Pressure Clinic Disclosures None of my financial holdings will have
More informationDysnatremias: All About the Salt? Internal Medicine Resident Lecture 1/12/16 Steve Schinker, MD
Dysnatremias: All About the Salt? Internal Medicine Resident Lecture 1/12/16 Steve Schinker, MD Water or salt? Dysnatremias In general, disorder of water balance, not sodium balance Volume status is tied
More informationCHF for Clinician. AtHomeCare.com
CHF for Clinician AtHomeCare.com CONTACT INFORMATION FOR CLIENTS Client s Name: SOC Date: Case Manager s Name: Phone #: Physician s Name: Phone: Emergency Contact Person s Name: Phone Number: MISSION STATEMENT
More informationPreoperative Cardiac Risk Assessment: Approach & Guidelines
Preoperative Cardiac Risk Assessment: Approach & Guidelines By, Liam Morris, MD., FACC (02/03/18) CPG : Clinical Practice Guidelines GDMT : Guidelines Directed Medical Therapy GWC : Guideline Writing Committee
More informationDifficult to Control HTN: It is not all the same. Structured approach to evaluation and treatment
Difficult to Control HTN: It is not all the same. Structured approach to evaluation and treatment Dmitri Vasin M.D. Nephrologist and ASH certified clinical hypertension specialist Bremerton, WA, USA Johnson
More informationDEPRESCRIBING IN THE ELDERLY
DEPRESCRIBING IN THE ELDERLY G E R I A T R I C S R E F R E S H E R D A Y W E D N E S D A Y, A P R I L 5 TH, 2 0 1 7 V É R O N I Q U E F R E N C H M E R K L E Y, M D, C C F P ( C O E ) B R U Y È R E C O
More informationPotassium A NNA VINNIKOVA, M. D.
Potassium A NNA VINNIOVA, M. D. DIVISION OF NEPHROLOGY Graphics by permission from The Fluid, Electrolyte and Acid-Base Companion, S. Faubel and J. Topf, http://www.pbfluids.com Do you want to hear a Sodium
More informationPRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas
PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney
More informationPolypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD
Polypharmacy and the Older Adult Leslie Baker, PharmD, BCGP Umanga Sharma, MD Objectives Identify what polypharmacy is Identify factors leading to polypharmacy Discuss consequences of polypharmacy Identify
More informationMedical History Form
Medical History Form Name: ; Birth date: / / ; Date: / / Person filling out form: ; Relationship: Thank you for taking the time to fill out this valuable information. This allows us to provide the best
More informationHypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg
Hypertension diagnosis (see detail document) Non-diabetic Diabetic Very elderly (older than 80 years) Target less than 140/90mmHg Target less than 130/80mmHg Consider SBP target less than 150mmHg Non-diabetic
More informationAttitudes, Beliefs, and Challenges: ABC s of Geriatrics. Guy Peifer, EMT-P
Attitudes, Beliefs, and Challenges: ABC s of Geriatrics Guy Peifer, EMT-P You are dispatched to a residence for an 87 year-old female that fell. Thoughts? Geriatrics 65 years and older 38% of patients
More informationRenee Flores, MD Division of Geriatrics & Palliative Medicine Department of Internal Medicine
Renee Flores, MD Division of Geriatrics & Palliative Medicine Department of Internal Medicine Define AMS and delirium Describe how to recognize and diagnose delirium Identify the predisposing or precipitating
More informationAtypical Presentation. Atypical Presentation Part II
Atypical Presentation Part II Atypical Presentation in Acutely Ill Older Adults Head to Toe Assessment General Weakness/FTT The Frailty Syndrome/Phenotype Dr. Peter O Connor Geriatrician Feb 2008 Physical
More informationSection 3, Lecture 2
59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect
More informationHypertension (JNC-8)
Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint
More informationObjectives. End-of-Life Exercise. Palliative Care Can Help Patients and Decrease 30-Day Hospital Readmissions.
Palliative Care Can Help Patients and Decrease 30-Day Hospital Readmissions. Objectives Describe how palliative care meets the needs of the patient and family. Discuss how out-patient palliative care can
More informationTravel Health Conference. April 27, 2018 Jamie Falk, BScPharm, PharmD
Travel Health Conference April 27, 2018 Jamie Falk, BScPharm, PharmD Presenter: Jamie Falk Drug interactions in travelers with chronic conditions I have no conflicts to disclose By attending this session
More informationHyponatremia and Hypomagnesemia
Hyponatremia and Hypomagnesemia Dre Kathy Ferguson,nephrologist Hyponatremia Salt and water imbalance Management Acute vs chronic Approach! How to make the correct diagnosis?! How to treat safely? Etiology!
More informationGeriatric Alterations Associated with Neurological Conditions
Geriatric Alterations Associated with Neurological Conditions I have no conflicts of interest. Julie Bronson The Older Adult According to the World Health Organization Africa 50-55 or 50-65 United Nations
More informationPolypharmacy & De-prescribing In Older Adults
Polypharmacy & De-prescribing In Older Adults Maryland Association of Osteopathic Physicians Annual Meeting September 15, 2018 Elizabeth Phung, DO Lead Clinical Associate Physician Beacham Center for Geriatric
More informationChapter Goal. Learning Objectives 9/12/2012. Chapter 36. Geriatrics. Use assessment findings to formulate management plan for geriatric patients
Chapter 36 Geriatrics Chapter Goal Use assessment findings to formulate management plan for geriatric patients Learning Objectives Describe dependent & independent living environments Identify local resources
More informationSAMPLE SAQ QUESTIONS RCPSC General Internal Medicine Examination (2015)
SAMPLE SAQ QUESTIONS RCPSC General Internal Medicine Examination (2015) Question 1 You are called by a relatively inexperienced physician practicing in a rural emergency department 3 hours from your center.
More informationDiabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018
Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018 Points to Ponder ASCVD is the leading cause of morbidity
More informationMedication Reviews within Care Homes. Catherine Armstrong
Medication Reviews within Care Homes Catherine Armstrong What is a Medication Review? A structured, critical examination of a patient s medicines with the objective of reaching an agreement with the patient
More informationDOWNTIME Physician Order CARD CHF Heart Failure
DOWNTIME Physician Clinical Category ADT/Comm unication Patient Status ASC Extended Recovery Observation Services Inpatient Admission CCU Admit as Inpatient History and Physical by House Physician Vital
More information9/15/2017. Joyce Turner RN Director of Clinical Program Development
Joyce Turner RN Director of Clinical Program Development A toxic response to an infection that spirals out of control attacking the body s own organs and tissues. The infection can be bacterial, viral
More informationMultiple Choice Questions
Multiple Choice Questions 25yo M presents without psychiatric or medical history, with complaint of tremor to the ER. He denies drinking alcohol but his friend at bedside takes you to the side and reports
More informationOverview INTRODUCTION 3/15/2018. Headache Emergencies. Other way to differentiate between them? Is there an easy way to differentiate between them?
Overview Headache Emergencies Primary versus Secondary headache disorder Red flags 4 cases of unusual headache emergencies Disclaimer: we will not talk about brain bleed as patients usually go the ED.
More informationDiseases of the Adrenal gland
Diseases of the Adrenal gland Adrenal insufficiency Cushing disease vs syndrome Pheochromocytoma Hyperaldostronism What are the layers of the adrenal gland?? And what does each layer produce?? What are
More informationHypertension and the 2017 Guidelines Meeting the Targets in Small Groups. Lisa Ivy APRN
Hypertension and the 2017 Guidelines Meeting the Targets in Small Groups Lisa Ivy APRN The 2017 Guideline is an Update to JNC7 New information regarding BP related risk of CVD Ambulatory BP monitoring
More informationPrinciples of Medication Use in Older Adults ANNE L. HUME, PHARMD PROFESSOR OF PHARMACY UNIVERSITY OF RHODE ISLAND
Principles of Medication Use in Older Adults ANNE L. HUME, PHARMD PROFESSOR OF PHARMACY UNIVERSITY OF RHODE ISLAND Financial Disclosure None of the planners, speakers, and/or members of the CME committee
More informationHypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC
HypertensionTreatment Guidelines Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC Objectives: Review the definition of the different stages of HTN. Review the current guidelines for treatment of HTN. Provided
More informationMultidisciplinary Geriatric Trauma Care Guideline
Multidisciplinary Geriatric Trauma Care Background Traumatic injury in the geriatric population is increasing in prevalence and is associated with higher mortality and complication rates comparted to younger
More informationAntihypertensive drugs: I. Thiazide and other diuretics:
Clinical assessment of hypertensive patient: You have to take history regarding the presence of other risk factors for CAb like diabetes mellitus, smoking, etc. Take history whether the patient takes medications
More informationIntroductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs
Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys
More informationDelirium. A Geriatric Syndrome. Jonathan McCaleb, MD, CMD, HMDC UNSOM, Assistant Professor of Medicine Geriatrics / Hospice & Palliative Medicine
Delirium A Geriatric Syndrome Jonathan McCaleb, MD, CMD, HMDC UNSOM, Assistant Professor of Medicine Geriatrics / Hospice & Palliative Medicine Introduction Common Serious Unrecognized: a medical emergency
More information2/25/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY OVERALL PRESCRIBING
Mean # Drugs/Resident 2/25/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY Darrell R. Abernethy, M.D., Ph.D. Associate Director for Drug Safety
More informationCardiorenal and Renocardiac Syndrome
And Renocardiac Syndrome A Vicious Cycle Cardiorenal and Renocardiac Syndrome Type 1 (acute) Acute HF results in acute kidney injury Type 2 Chronic cardiac dysfunction (eg, chronic HF) causes progressive
More informationWe are delighted to have Dr. Roetzheim with us today to discuss Managing Hypertension in Older Adult Patients.
Richard Roetzheim, MD, MSPH is Professor and Chair, Department of Family Medicine at the University of South Florida Morsani College of Medicine. Dr. Roetzheim has considerable experience leading NIH funded
More information2/26/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY
PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY Darrell R. Abernethy, M.D., Ph.D. Associate Director for Drug Safety Office of Clinical Pharmacology
More informationHeart Failure. Dr. William Vosik. January, 2012
Heart Failure Dr. William Vosik January, 2012 Questions for clinicians to ask Is this heart failure? What is the underlying cause? What are the associated disease processes? Which evidence-based treatment
More informationNetwork Hypertension Algorithm
Network Hypertension Algorithm Content Review and Approval: This document is subject to review, revision, and (re)approval by the Clinical Integration and Oversight Committee (CIOC) annually and following
More informationFamily Medicine for English language students of Medical University of Lodz. Seminar 12. Elderly care. Przemysław Kardas MD PhD
Family Medicine for English language students of Medical University of Lodz Seminar 12 Elderly care Przemysław Kardas MD PhD Europe is facing demographic challenge 2014 2080 2 3 Old vs young: major differences
More informationSTOPP START Toolkit Supporting Medication Review in the Older Person
STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,
More informationCOMPOSITION. A film coated tablet contains. Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar (Film coated tablets) Irbesartan
Rotazar (Film coated tablets) Irbesartan Rotazar 75 mg, 150 mg, 300 mg COMPOSITION A film coated tablet contains Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar 75 mg, 150 mg, 300 mg PHARMACOLOGICAL
More informationDementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist
Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution
More informationComfort with Geriatric Emergency Medicine Competencies: A Survey of Canadian Emergency Medicine Residents
Comfort with Geriatric Emergency Medicine Competencies: A Survey of Canadian Emergency Medicine Residents Tristan Snider HBSc MD FRCP Emergency Medicine Resident, University of Toronto Don Melady BA MD
More informationHeart Failure Clinician Guide JANUARY 2018
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.
More information:{ic0fp'16. Geriatric Medicine: Optimal Heart Health Amid Changing Guidelines. (and the Evidence for When to Stray) Kevin Overbeck, DO
:{ic0fp'16 ACOFP 53 rd Annual Convention & Scientific Seminars Geriatric Medicine: Optimal Heart Health Amid Changing Guidelines (and the Evidence for When to Stray) Kevin Overbeck, DO Optimal Heart Health
More informationAntihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment
Approaches to Hypertension Treatment Antihypertensives Inhibit Sympathetic impulses Inhibit contractility Inhibit heart rate Inhibit vasoconstriction Inhibit smooth muscle function Inhibit RAAS Inhibit
More informationHeart Failure Clinician Guide JANUARY 2016
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.
More informationResident Assessment Best Practices M E G A N M. G R A E S E R, D N P, G N P - BC P H Y S I C I A N H O U S E C A L L S, L L C
Resident Assessment Best Practices M E G A N M. G R A E S E R, D N P, G N P - BC P H Y S I C I A N H O U S E C A L L S, L L C Who are you assessing? Elders that needing to make a transition in their care
More informationIntroductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs
Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs Dopaminergic Drugs: Actions Symptoms of parkinsonism are caused by depletion of dopamine in CNS Amantadine: makes more of dopamine available
More informationUBMD Internal Medicine
UBMD Internal Medicine Clinical Documentation Example Established Outpatient Visit - 99215 Pat Kisiel-Neunder, Compliance Administrator Email: pkisieln@buffalo.edu Regulations The following information
More informationTable of Contents: Amyotrophic Lateral Sclerosis (ALS)
Guidelines for Hospice Admission Amyotrophic Lateral Sclerosis (ALS) Cancer Cerebral Vascular Accident / Stroke or Coma Dementia / Alzheimer s Failure to Thrive Adults Heart Disease / CHF HIV Disease Huntington
More informationAntihypertensive drugs SUMMARY Made by: Lama Shatat
Antihypertensive drugs SUMMARY Made by: Lama Shatat Diuretic Thiazide diuretics The loop diuretics Potassium-sparing Diuretics *Hydrochlorothiazide *Chlorthalidone *Furosemide *Torsemide *Bumetanide Aldosterone
More informationEstimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches
Heart Failure: Management of a Chronic Disease Jenny Bauerly RN, CHFN, APRN-BC Heart Failure (HF) Definition A complex clinical syndrome that can result from any structural or functional cardiac disorder
More informationM2 TEACHING UNDERSTANDING PHARMACOLOGY
M2 TEACHING UNDERSTANDING PHARMACOLOGY USING CVS SYSTEM AS AN EXAMPLE NIGEL FONG 2 JAN 2014 TODAY S OBJECTIVE Pharmacology often seems like an endless list of mechanisms and side effects to memorize. To
More information